| Date | Time | Source | Headline | Symbol | Company |
| 28/04/2009 | 21:00 | Business Wire | Allos Therapeutics to Report First Quarter 2009 Results on May 5, 2009 | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 20/04/2009 | 12:54 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 19/04/2009 | 20:00 | Business Wire | Allos Therapeutics’ Pralatrexate Demonstrates Anticancer Activity in Multiple Cancer Cell Lines | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 15/04/2009 | 13:00 | Business Wire | Allos Therapeutics to Present at the American Association for Cancer Research Annual Meeting 2009 | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 03/04/2009 | 21:05 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 03/04/2009 | 21:00 | Business Wire | Allos Therapeutics Announces Closing of Common Stock Offering | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 02/04/2009 | 21:14 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 02/04/2009 | 21:10 | Edgar (US Regulatory) | Prospectus filed pursuant to Rule 424(b)(5) (424B5) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 31/03/2009 | 14:06 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 31/03/2009 | 14:00 | Business Wire | Allos Therapeutics Announces Pricing of Common Stock Offering | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 27/03/2009 | 21:35 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 26/03/2009 | 12:00 | Business Wire | Allos Therapeutics to Present at the 4th Annual Citi Biotech Day | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 25/03/2009 | 12:06 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 25/03/2009 | 12:00 | Business Wire | Allos Therapeutics Submits New Drug Application for Pralatrexate for Patients with Relapsed or Refractory Peripheral T-cell L... | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 24/03/2009 | 21:30 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 24/03/2009 | 12:06 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 24/03/2009 | 12:00 | Business Wire | Allos Therapeutics Appoints David M. Stout to Its Board of Directors | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 20/03/2009 | 20:58 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 17/03/2009 | 12:08 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 17/03/2009 | 12:00 | Business Wire | Allos Therapeutics’ Pralatrexate Granted Orphan Medicinal Product Designation for the Treatment of Bladder Cancer by the Eu... | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 16/03/2009 | 22:29 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 16/03/2009 | 22:27 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 16/03/2009 | 22:25 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 12/03/2009 | 20:49 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 03/03/2009 | 21:03 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 03/03/2009 | 21:00 | Business Wire | Allos Therapeutics Reports 2008 Results | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 27/02/2009 | 21:52 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 26/02/2009 | 21:00 | Business Wire | Allos Therapeutics to Report 2008 Results on March 3, 2009 | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 26/02/2009 | 00:49 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 26/02/2009 | 00:48 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |